glp1versus.com is an independent comparison engine for GLP-1 and related obesity medications. We help people understand how drugs like Ozempic, Wegovy, Mounjaro, and Zepbound differ — so they can have better-informed conversations with their doctors.
What We Do
We build side-by-side drug comparisons backed by FDA prescribing information and published clinical trials. Every comparison includes efficacy data, side effect rates, cost breakdowns, dosing schedules, and approval details.
What We Don’t Do
- We do not prescribe or recommend medications
- We do not sell drugs or operate a pharmacy
- We do not market compounded products as substitutes for FDA-approved medications
- We do not provide individualized medical advice
Our Principles
- Independence. We are not owned by or affiliated with any pharmaceutical company, telehealth platform, or pharmacy.
- Evidence first. We lead with FDA-approved indications and peer-reviewed trial data, not marketing claims.
- Transparency. Every data point is sourced. Our methodology is public.
- No off-label claims. We report what the FDA has approved and what trials have measured.
Medical Review
Content on glp1versus.com is reviewed by qualified healthcare professionals. Each page displays the reviewer name, credentials, and date of last review.
Dr. Elena Vance, DO
Board-certified in internal medicine with a focus on endocrinology and obesity medicine. Dr. Vance reviews all clinical data, drug comparisons, and medical claims published on this site.
Part of IsItLabs
glp1versus.com is part of IsItLabs, a portfolio of independent comparison tools for high-intent health and wellness decisions.
This content is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions. See our full medical disclaimer.